Welcome to LookChem.com Sign In|Join Free

CAS

  • or

106788-62-9

Post Buying Request

106788-62-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

106788-62-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 106788-62-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,7,8 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 106788-62:
(8*1)+(7*0)+(6*6)+(5*7)+(4*8)+(3*8)+(2*6)+(1*2)=149
149 % 10 = 9
So 106788-62-9 is a valid CAS Registry Number.

106788-62-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 9H-fluoren-2-ylthiourea

1.2 Other means of identification

Product number -
Other names N-(9H-fluoren-2-yl)thiourea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:106788-62-9 SDS

106788-62-9Downstream Products

106788-62-9Relevant articles and documents

Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors

Kang, Iou-Jiun,Wang, Li-Wen,Yeh, Teng-Kuang,Lee, Chung-Chi,Lee, Yen-Chun,Hsu, Sheng-Ju,Wu, Yen-Shian,Wang, Jing-Chyi,Chao, Yu-Sheng,Yueh, Andrew,Chern, Jyh-Haur

experimental part, p. 6414 - 6421 (2010/10/04)

A series of novel conformationally-restricted thiourea analogs were designed, synthesized, and evaluated for their anti-HCV activity. Herein we report the synthesis, structure-activity relationships (SARs), and pharmacokinetic properties of this new class of thiourea compounds that showed potent inhibitory activities against HCV in the cell-based subgenomic HCV replicon assay. Among compounds tested, the fluorene compound 4b was found to possess the most potent activity (EC50 = 0.3 μM), lower cytotoxicity (CC50 > 50 μM), and significantly better pharmacokinetic properties compared to its corresponding fluorenone compound 4c.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 106788-62-9